ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.

David J Messenheimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.